Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Plos One|October 6, 2015
Anti-Apoptotic Effects of 3,3',5-Triiodo-L-Thyronine in the Liver of Brain-Dead RatsRolando A Rebolledo, Anne C Van Erp, Petra J Ottens, et al.Critical Care Medicine|February 4, 2010
Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal functionWillemijn N Nijboer, Petra J Ottens, Antony van Dijk, et al.Journal of Translational Medicine|June 3, 2014
Prednisolone has a positive effect on the kidney but not on the liver of brain dead rats: a potencial role in complement activationRolando Rebolledo, Bo Liu, Mohammed Z Akhtar, et al.Biomed Research International|June 20, 2015
Steroid Anti-Inflammatory Effects Did Not Improve Organ Quality in Brain-Dead RatsRolando A Rebolledo, Bo Liu, Mohammed Z Akhtar, et al.Journal of Translational Medicine|November 15, 2013
Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryWillem G van Rijt, Gertrude J Nieuwenhuijs-Moeke, Harry van Goor, et al.Scientific Reports|July 24, 2025
Inhibition of the complement component C5 and the Toll-like receptor molecule CD14 prevents systemic and local kidney inflammation in mice experiencing brain deathTom E Mollnes, Neeltina M Jager, Petra J Ottens, et al.Laboratory Animals|July 21, 2007
The gradual onset brain death model: a relevant model to study organ donation and its consequences on the outcome after transplantationJoe L P Kolkert, Nils A 't Hart, Antony van Dijk, et al.Frontiers in Pharmacology|March 11, 2021
Methylprednisolone Treatment in Brain Death-Induced Lung Inflammation-A Dose Comparative Study in RatsJudith E Van Zanden, Nils A 't Hart, Petra J Ottens, et al.Journal of Translational Medicine|May 20, 2016
Slow induction of brain death leads to decreased renal function and increased hepatic apoptosis in ratsRolando A Rebolledo, Dane Hoeksma, Christina M V Hottenrott, et al.Journal of Translational Medicine|January 11, 2013
ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injuryWillem G van Rijt, Gertrude J Nieuwenhuijs-Moeke, Harry van Goor, et al.Pageof 4